Abstract
AbstractMedical conditions with effective therapies are usually managed with objective measurement and therapeutic targets. Parkinson’s disease has effective therapies, but continuous objective measurement has only recently become available. This blinded, controlled study examined whether management of Parkinson’s disease was improved when clinical assessment and therapeutic decisions were aided by objective measurement. The primary endpoint was improvement in the Movement Disorder Society-United Parkinson’s Disease Rating Scale’s (MDS-UPDRS) Total Score. In one arm, objective measurement assisted doctors to alter therapy over successive visits until objective measurement scores were in target. Patients in the other arm were conventionally assessed and therapies were changed until judged optimal. There were 75 subjects in the objective measurement arm and 79 in the arm with conventional assessment and treatment. There were statistically significant improvements in the moderate clinically meaningful range in the MDS-UPDRS Total, III, IV scales in the arm using objective measurement, but not in the conventionally treated arm. These findings show that global motor and non-motor disability is improved when management of Parkinson’s disease is assisted by objective measurement.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Clinical Neurology,Neurology
Reference24 articles.
1. Altman, D. G. Assessing new methods of clinical measurement. Br. J. Gen. Pract. 59, 399–400 (2009).
2. Maetzler, W., Klucken, J. & Horne, M. A clinical view on the development of technology-based tools in managing Parkinson’s disease. Mov. Disord. 31, 1263–1271 (2016).
3. Farzanehfar, P., Braybrook, M., Kotschet, K. & Horne, M. Objective measurement in clinical care of patients with parkinson’s disease: an RCT using the PKG. In 20th International Congress of Parkinons’ Disorders and Movement Disorders. Berlin, Germany (2016).
4. Farzanehfar, P. et al. Objective measurement in routine care of people with Parkinson’s disease improves outcomes. NPJ Parkinsons Dis. 4, 10 (2018).
5. Shulman, L. M. et al. The clinically important difference on the unified Parkinson’s disease rating scale. Arch. Neurol. 67, 64–70 (2010).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献